535 related articles for article (PubMed ID: 12824291)
1. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
2. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
3. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.
Hayashida T; Schnaper HW
J Am Soc Nephrol; 2004 Aug; 15(8):2032-41. PubMed ID: 15284289
[TBL] [Abstract][Full Text] [Related]
4. Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F413-22. PubMed ID: 12759229
[TBL] [Abstract][Full Text] [Related]
5. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2004 Jan; 279(4):2632-9. PubMed ID: 14610066
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression.
Hayashida T; Poncelet AC; Hubchak SC; Schnaper HW
Kidney Int; 1999 Nov; 56(5):1710-20. PubMed ID: 10571779
[TBL] [Abstract][Full Text] [Related]
7. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
[TBL] [Abstract][Full Text] [Related]
8. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
[TBL] [Abstract][Full Text] [Related]
9. Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1.
Li YC; Ding XS; Li HM; Zhang C
Clin Exp Pharmacol Physiol; 2013 Sep; 40(9):635-43. PubMed ID: 23772748
[TBL] [Abstract][Full Text] [Related]
10. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
Poncelet AC; Schnaper HW
J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
[TBL] [Abstract][Full Text] [Related]
11. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
13. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
15. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
[TBL] [Abstract][Full Text] [Related]
16. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
17. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells.
Hong HK; Song CY; Kim BC; Lee HS
Transl Res; 2006 Oct; 148(4):171-9. PubMed ID: 17002919
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF.
Dai C; Liu Y
J Am Soc Nephrol; 2004 Jun; 15(6):1402-12. PubMed ID: 15153551
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway.
Chin BY; Mohsenin A; Li SX; Choi AM; Choi ME
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F495-504. PubMed ID: 11181412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]